Pain and dyspnea control during awake fiberoptic bronchoscopy in critically ill patients: safety and efficacy of remifentanil target-controlled infusion

Clicks: 175
ID: 265807
2021
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #42 of 131 articles by views in annals of intensive care

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 131 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Flexible fiberoptic bronchoscopy is frequently used in intensive care unit, but is a source of discomfort, dyspnea and anxiety for patients. Our objective was to assess the feasibility and tolerance of a sedation using remifentanil target-controlled infusion, ...
Reference Key
pham2021annalspain Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Margot Caron, Antoine Parrot, Alexandre Elabbadi, Sophie Dupeyrat, Matthieu Turpin, Thomas Baury, Sacha Rozencwajg, Clarisse Blayau, Jean-Pierre Fulgencio, Aude Gibelin, Pierre-Yves Blanchard, Séverine Rodriguez, Daisy Daigné, Marie-Cécile Allain, Muriel Fartoukh, Tài Pham;Margot Caron;Antoine Parrot;Alexandre Elabbadi;Sophie Dupeyrat;Matthieu Turpin;Thomas Baury;Sacha Rozencwajg;Clarisse Blayau;Jean-Pierre Fulgencio;Aude Gibelin;Pierre-Yves Blanchard;Séverine Rodriguez;Daisy Daigné;Marie-Cécile Allain;Muriel Fartoukh;Tài Pham;
Journal annals of intensive care
Year 2021
DOI
10.1186/s13613-021-00832-6
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.